西班牙裔与欧洲裔患者接受丝裂霉素C小梁切除术的结局比较
这项单中心回顾性匹配队列研究比较了西班牙裔与欧洲裔患者初次丝裂霉素C小梁切除术的结局,西班牙裔111眼与欧洲裔111眼按年龄、术者、晶状体状态和手术日期匹配。5年条件成功率在西班牙裔患者中较低(标准A:52% vs 68%),西班牙裔与更高的失败率相关(风险比范围2.07-3.03,P<.001)。
要点
- 5年条件成功率西班牙裔 vs 欧洲裔:标准A 52% vs 68%,标准B 45% vs 61%,标准C 31% vs 51%。
- 多变量分析中西班牙裔与所有完全和条件成功标准的更高失败率相关(HR 2.07-3.03,P<.001)。
- 早期滤过泡渗漏西班牙裔14眼 vs 欧洲裔6眼(P=.10)。
核心结论
- 在本研究中,与欧洲裔相比,西班牙裔与初次丝裂霉素C小梁切除术后更高的失败率相关。
- 作者认为,在考虑为西班牙裔患者行青光眼手术时应考虑这些发现,尤其是若未来研究证实这些结果并解决本单中心回顾性研究的局限性。
研究设计与样本
- 单中心回顾性匹配队列研究,纳入西班牙裔111眼(96例患者)与欧洲裔111眼(108例患者),按年龄(±5岁)、术者、晶状体状态和手术日期(±1年)匹配。
- 暴露为初次丝裂霉素C小梁切除术,民族由患者自我认定。
主要发现
- 西班牙裔队列59例女性(61.5%)和37例男性(38.5%),平均(SD)年龄69.1(9.9)岁;欧洲裔队列53例女性(49.1%)和55例男性(50.9%),平均(SD)年龄69.2(9.4)岁。
- 5年条件成功率西班牙裔 vs 欧洲裔:标准A(眼压≤18 mm Hg且眼压降低≥20%或用药减少≥2种)52% vs 68%(差值16.7%;95%CI 4.0%-29.4%;P<.001)。
- 5年条件成功率西班牙裔 vs 欧洲裔:标准B(眼压≤15 mm Hg且眼压降低≥25%或用药减少≥2种)45% vs 61%(差值16.2%;95%CI 3.2%-29.1%;P=.01)。
- 5年条件成功率西班牙裔 vs 欧洲裔:标准C(眼压≤12 mm Hg且眼压降低≥30%或用药减少≥2种)31% vs 51%(差值20.0%;95%CI 7.3%-32.6%;P=.002)。
- 多变量分析中西班牙裔与所有完全和条件成功标准的更高失败率相关(风险比范围2.07-3.03;P<.001);早期滤过泡渗漏西班牙裔14眼 vs 欧洲裔6眼(P=.10)。
关键数值与推荐
- 标准A定义条件成功为最终眼压≤18 mm Hg且眼压降低≥20%或用药减少≥2种。
- 标准B定义条件成功为最终眼压≤15 mm Hg且眼压降低≥25%或用药减少≥2种。
- 标准C定义条件成功为最终眼压≤12 mm Hg且眼压降低≥30%或用药减少≥2种。
- 完全成功要求满足上述标准且不使用药物。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文明确称本研究为单中心回顾性研究。
- 作者指出这些发现需在未来研究中证实,并需解决本单中心回顾性研究的某些局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Previous studies suggest that race or ethnicity may influence glaucoma surgical outcomes. OBJECTIVE: To compare outcomes of initial trabeculectomy with mitomycin C (MMC) in patients of Hispanic descent with those in patients of European descent and identify prognostic factors for failure. DESIGN, SETTING, AND PARTICIPANTS: This retrospective matched-cohort study was conducted at a single-tertiary academic center. The study included 111 eyes from 96 patients of Hispanic descent that were matched to 111 eyes from 108 patients of European descent, based on age (±5 years), surgeon, lens status, and surgery date (±1 year). Ethnicity was self-determined by patients. EXPOSURE: Initial trabeculectomy with MMC. MAIN OUTCOME MEASURES: Criteria A, B, and C defined qualified success as final intraocular pressure (IOP) of 18 mm Hg or less, 15 mm Hg or less, and 12 mm Hg or less, respectively, with corresponding IOP reduction of 20% or more, 25% or more, and 30% or more, or a decrease of 2 or more medications. Complete success required meeting the above criteria without medication use. Kaplan-Meier survival curves compared patients of Hispanic descent and patients of European descent success rates with log-rank tests. Cox proportional hazard models estimated the influence of ethnicity on surgical success adjusting for confounders. RESULTS: The Hispanic descent cohort included 59 females (61.5%) and 37 males (38.5%) with a mean (SD) age of 69.1 (9.9) years. The European descent cohort included 53 females (49.1%) and 55 males (50.9%) with a mean (SD) age of 69.2 (9.4) years. Qualified success rates at 5 years in Hispanic descent and European descent patients were 52% and 68% based on criteria A (difference, 16.7%; 95% CI, 4.0%-29.4%; P < .001), 45% and 61% according to criteria B (difference, 16.2%; 95% CI, 3.2%-29.1%; P = .01), and 31% and 51% based on criteria C (difference, 20.0%; 95% CI, 7.3%-32.6%; P = .002). On multivariable analyses, Hispanic descent was associated with higher failure rates with all complete and qualified success criteria (hazard ratio range, 2.07-3.03; P < .001). Early bleb leaks were more frequent in patients of Hispanic descent (14 eyes vs 6 eyes; P = .10). CONCLUSION AND RELEVANCE: In this study, Hispanic descent was associated with higher failure rate after initial trabeculectomy with adjunctive MMC compared with European descent. These findings need to be considered when glaucoma surgery is contemplated in patients of Hispanic descent, especially if these findings are confirmed in future studies that address some of the limitations of this single-center retrospective investigation.
引用
- Besharati S, Mohammadzadeh V, Ashrafkhorasani M, et al. Outcomes of Trabeculectomy With Mitomycin C in Patients of Hispanic vs European Descent. JAMA Ophthalmol. 2025. PMID: 40839377. doi:10.1001/jamaophthalmol.2025.2815
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。